Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 709

1.

C/EBPα and the Vitamin D Receptor Cooperate in the Regulation of Cathelicidin in Lung Epithelial Cells.

Dhawan P, Wei R, Sun C, Gombart AF, Koeffler HP, Diamond G, Christakos S.

J Cell Physiol. 2014 Jul 30. doi: 10.1002/jcp.24729. [Epub ahead of print]

PMID:
25078430
[PubMed - as supplied by publisher]
2.

IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion.

Sarkissyan S, Sarkissyan M, Wu Y, Cardenas J, Koeffler HP, Vadgama JV.

PLoS One. 2014 Jul 25;9(7):e103534. doi: 10.1371/journal.pone.0103534. eCollection 2014.

PMID:
25062088
[PubMed - in process]
Free PMC Article
3.

KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.

Zheng Y, Gery S, Sun H, Shacham S, Kauffman M, Koeffler HP.

Cancer Chemother Pharmacol. 2014 Jul 17. [Epub ahead of print]

PMID:
25030088
[PubMed - as supplied by publisher]
4.

LAMC2 as a therapeutic target for cancers.

Garg M, Braunstein G, Koeffler HP.

Expert Opin Ther Targets. 2014 Sep;18(9):979-82. doi: 10.1517/14728222.2014.934814. Epub 2014 Jun 30.

PMID:
24976367
[PubMed - in process]
5.

The genomic landscape of nasopharyngeal carcinoma.

Lin DC, Meng X, Hazawa M, Nagata Y, Varela AM, Xu L, Sato Y, Liu LZ, Ding LW, Sharma A, Goh BC, Lee SC, Petersson BF, Yu FG, Macary P, Oo MZ, Ha CS, Yang H, Ogawa S, Loh KS, Koeffler HP.

Nat Genet. 2014 Aug;46(8):866-71. doi: 10.1038/ng.3006. Epub 2014 Jun 22.

PMID:
24952746
[PubMed - in process]
6.

KPT-330 has antitumour activity against non-small cell lung cancer.

Sun H, Hattori N, Chien W, Sun Q, Sudo M, E-Ling GL, Ding L, Lim SL, Shacham S, Kauffman M, Nakamaki T, Koeffler HP.

Br J Cancer. 2014 Jul 15;111(2):281-91. doi: 10.1038/bjc.2014.260. Epub 2014 Jun 19.

PMID:
24946002
[PubMed - in process]
7.

Targeting genetic lesions in esophageal cancer.

Lin DC, Wang MR, Koeffler HP.

Cell Cycle. 2014 Jul 1;13(13):2013-4. doi: 10.4161/cc.29458. Epub 2014 Jun 5. No abstract available.

PMID:
24901941
[PubMed - in process]
Free Article
8.

LNK (SH2B3): paradoxical effects in ovarian cancer.

Ding LW, Sun QY, Lin DC, Chien W, Hattori N, Dong XM, Gery S, Garg M, Doan NB, Said JW, Xiao JF, Yang H, Liu LZ, Meng X, Huang RY, Tang K, Koeffler HP.

Oncogene. 2014 Apr 7. doi: 10.1038/onc.2014.34. [Epub ahead of print]

PMID:
24704825
[PubMed - as supplied by publisher]
9.

Genomic and molecular characterization of esophageal squamous cell carcinoma.

Lin DC, Hao JJ, Nagata Y, Xu L, Shang L, Meng X, Sato Y, Okuno Y, Varela AM, Ding LW, Garg M, Liu LZ, Yang H, Yin D, Shi ZZ, Jiang YY, Gu WY, Gong T, Zhang Y, Xu X, Kalid O, Shacham S, Ogawa S, Wang MR, Koeffler HP.

Nat Genet. 2014 May;46(5):467-73. doi: 10.1038/ng.2935. Epub 2014 Mar 30.

PMID:
24686850
[PubMed - indexed for MEDLINE]
10.

An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions.

Kanda J, Mori K, Kawabata H, Kuwabara T, Mori KP, Imamaki H, Kasahara M, Yokoi H, Mizumoto C, Thoennissen NH, Koeffler HP, Barasch J, Takaori-Kondo A, Mukoyama M, Nakao K.

Clin Exp Nephrol. 2014 Mar 6. [Epub ahead of print]

PMID:
24599361
[PubMed - as supplied by publisher]
11.

Deficiency of CCAAT/enhancer binding protein-epsilon reduces atherosclerotic lesions in LDLR-/- mice.

Okamoto R, Gery S, Gombart AF, Wang X, Castellani LW, Akagi T, Chen S, Arditi M, Ho Q, Lusis AJ, Li Q, Koeffler HP.

PLoS One. 2014 Jan 28;9(1):e85341. doi: 10.1371/journal.pone.0085341. eCollection 2014.

PMID:
24489659
[PubMed - in process]
Free PMC Article
12.

An emerging role of PARK2 in cancer.

Xu L, Lin DC, Yin D, Koeffler HP.

J Mol Med (Berl). 2014 Jan;92(1):31-42. doi: 10.1007/s00109-013-1107-0. Epub 2013 Dec 3. Review.

PMID:
24297497
[PubMed - indexed for MEDLINE]
13.

Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).

Lin L, Gaut D, Hu K, Yan H, Yin D, Koeffler HP.

Int J Oncol. 2014 Feb;44(2):557-62. doi: 10.3892/ijo.2013.2205. Epub 2013 Dec 2.

PMID:
24297065
[PubMed - in process]
Free PMC Article
14.

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler HP, Klein HU, Dugas M, Aburatani H, Kohlmann A, Miyano S, Haferlach C, Kern W, Ogawa S.

Leukemia. 2014 Feb;28(2):241-7. doi: 10.1038/leu.2013.336. Epub 2013 Nov 13.

PMID:
24220272
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.

Garg M, Kanojia D, Okamoto R, Jain S, Madan V, Chien W, Sampath A, Ding LW, Xuan M, Said JW, Doan NB, Liu LZ, Yang H, Gery S, Braunstein GD, Koeffler HP.

J Clin Endocrinol Metab. 2014 Jan;99(1):E62-72. doi: 10.1210/jc.2013-2994. Epub 2013 Dec 20.

PMID:
24170107
[PubMed - indexed for MEDLINE]
16.

PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells.

Chien W, Lee KL, Ding LW, Wuensche P, Kato H, Doan NB, Poellinger L, Said JW, Koeffler HP.

Br J Cancer. 2013 Oct 1;109(7):1795-804. doi: 10.1038/bjc.2013.531. Epub 2013 Sep 3.

PMID:
24002598
[PubMed - indexed for MEDLINE]
17.

Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.

Kon A, Shih LY, Minamino M, Sanada M, Shiraishi Y, Nagata Y, Yoshida K, Okuno Y, Bando M, Nakato R, Ishikawa S, Sato-Otsubo A, Nagae G, Nishimoto A, Haferlach C, Nowak D, Sato Y, Alpermann T, Nagasaki M, Shimamura T, Tanaka H, Chiba K, Yamamoto R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Nakamaki T, Ishiyama K, Nolte F, Hofmann WK, Miyawaki S, Chiba S, Mori H, Nakauchi H, Koeffler HP, Aburatani H, Haferlach T, Shirahige K, Miyano S, Ogawa S.

Nat Genet. 2013 Oct;45(10):1232-7. doi: 10.1038/ng.2731. Epub 2013 Aug 18.

PMID:
23955599
[PubMed - indexed for MEDLINE]
18.

BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.

Swaminathan S, Huang C, Geng H, Chen Z, Harvey R, Kang H, Ng C, Titz B, Hurtz C, Sadiyah MF, Nowak D, Thoennissen GB, Rand V, Graeber TG, Koeffler HP, Carroll WL, Willman CL, Hall AG, Igarashi K, Melnick A, Müschen M.

Nat Med. 2013 Aug;19(8):1014-22. doi: 10.1038/nm.3247. Epub 2013 Jul 14.

PMID:
23852341
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer.

Chan D, Zheng Y, Tyner JW, Chng WJ, Chien WW, Gery S, Leong G, Braunstein GD, Koeffler HP.

J Cancer Res Clin Oncol. 2013 Sep;139(9):1507-14. doi: 10.1007/s00432-013-1465-6. Epub 2013 Jul 4.

PMID:
23824064
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Novel Gemini vitamin D3 analogs: large structure/function analysis and ability to induce antimicrobial peptide.

Okamoto R, Gery S, Kuwayama Y, Borregaard N, Ho Q, Alvarez R, Akagi T, Liu GY, Uskokovic MR, Koeffler HP.

Int J Cancer. 2014 Jan 1;134(1):207-17. doi: 10.1002/ijc.28328. Epub 2013 Jul 16.

PMID:
23775785
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk